| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
1987-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c058dec5dcb1b0413e11e11a0802e10d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d6f373a1099624697687f8437c9e876 |
| publicationDate |
1987-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0250192-A2 |
| titleOfInvention |
Therapeutic compositions |
| abstract |
Tumor necrosis factor-alpha is employed in the manufacture of a medicament for the treatment of infectious disease. Resultant formulations are particularly suitable for those infections consequent to a defect in phagocytic cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0242752-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0242752-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4933322-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9213865-A1 |
| priorityDate |
1986-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |